Search
Search Results
##search.searchResults.foundPlural##
-
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2375HTML: 675PDF: 1423 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3572PDF: 1358HTML: 2400Fi.1 Gritti.Rambaldi: 257 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2807PDF: 824HTML: 2333 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1425PDF: 638HTML: 4192 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3424PDF: 1334HTML: 2373 -
SOLITARY PLASMACYTOMA
4258PDF: 2270HTML: 1417fIGURES 1,2: 274 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1100PDF: 1297HTML: 137 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
238PDF: 745HTML: 70 -
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.
3591PDF: 1106HTML: 1046Figure 1: 244 -
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1513PDF: 507HTML: 308 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1709PDF: 1128HTML: 496 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2057PDF: 870HTML: 2224Table 1: 228Table 2: 243Table 3: 239Table 4: 235Table 5: 234Tble 6: 230Cover Letter: 245Greene Tab.7: 250 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1804PDF: 789HTML: 2358 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1633PDF: 959HTML: 389 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2218PDF: 1381HTML: 3517 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7934PDF: 2513HTML: 2151Table 1.: 270Table 2.: 279Table 3.: 260Table 4.: 257 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1459PDF: 981HTML: 1680Figure 1: 217 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4659PDF: 1809HTML: 1311 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1566HTML: 411PDF: 1013Suppl. Files: 510 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1611PDF: 959HTML: 1025figures: 228table 1: 229table2: 232table3: 235 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3760PDF: 2625HTML: 1673







